Stay updated on SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays a newer revision tag: Revision: v3.5.4, replacing the prior v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-19T11:27:18.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page's revision changed from v3.5.2 to v3.5.3, indicating a small backend update. It reflects an internal version bump rather than a change to the displayed study information.
    Difference
    0.0%
    Check dated 2026-04-27T20:14:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T16:20:17.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T22:09:41.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.4.3 implemented. No visible changes to study data, eligibility criteria, or study details.
    Difference
    0.0%
    Check dated 2026-03-08T13:36:57.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; no study data or page functionality appears to be altered.
    Difference
    0.0%
    Check dated 2026-02-14T22:45:14.000Z thumbnail image

Stay in the know with updates to SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page.